Standardizing the cell count in CAR T cell therapy

Considering the competitive clinical landscape of CAR-cell therapies, accelerated development timelines and the variable nature of cellular therapies, designing a robust process should begin early to make transitioning to the clinic and scaling upwards or outwards smoother.

In this eBook, ChemoMetec explains the fundamentals of accurate and precise cell counting in that process, highlighting the unique features of its flagship cell counter, the NucleoCounter^® NC-202™.